PendiumPendium

Step 1 of 9

Optum Rx owns the PBM category in AI memory, but is losing the service conversation to disruptors.

The brand's visibility is anchored in its massive scale, yet consumer discoverability is hampered by a significant volume of unresolved negative feedback in the training data.

Optum Rx's baseline score
32/100
Lowlots of room to grow

Optum Rx has dominant visibility as a market incumbent but faces a trust deficit in AI-generated consumer recommendations. While all platforms recognize it as a top-tier PBM, they frequently surface caveats about customer service and delivery delays found on Reddit and Trustpilot.

What we see
  • Optum Rx is named as a top-3 provider in almost any 'who are the biggest PBMs' prompt, but rarely as a 'best' recommendation for individuals.
  • Reddit threads from 2025-2026 act as a powerful negative anchor for Gemini and ChatGPT when users ask about home delivery reliability.
  • The brand's 2026 push into transparent pricing is starting to show up in news-grounded Gemini answers, offering a counter-narrative to traditional PBM criticism.
  • There is a notable lack of positive third-party editorial reviews (like Wirecutter) which makes AI default to neutral or service-focused descriptions.
  • Competitors like Mark Cuban's Cost Plus Drugs are winning the 'alternatives' and 'transparency' prompts by a wide margin across all platforms.
Business goals Optum Rx is likely trying to hit
  • Improve member retention through expanded home delivery adoption
  • Defend market share against transparent-pricing disruptors like Cost Plus Drugs
  • Reduce customer support costs by shifting members to AI-enabled self-service
  • Stabilize independent pharmacy network relations following pricing model shifts